Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 19 February 2009, Vol. 113, No. 8, pp. 1786-1793.
Prepublished online as a Blood First Edition Paper on November 24, 2008; DOI 10.1182/blood-2008-08-174565.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
blood-2008-08-174565v1
113/8/1786    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maxson, J. E
Right arrow Articles by Zhang, A.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maxson, J. E
Right arrow Articles by Zhang, A.-S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted August 15, 2008
Accepted November 11, 2008

Processing of hemojuvelin requires retrograde trafficking to the Golgi in HepG2 cells

Julia E Maxson, Caroline A Enns, and An-Sheng Zhang*

Department of Cell and Developmental Biology, Oregon Health & Science University, Portland, OR, United States

* Corresponding author; email: zhanga{at}ohsu.edu.

Hemojuvelin (HJV) was recently identified as a critical regulator of iron homeostasis. It is either associated with cell membranes through a GPI-anchor or released as a soluble form. Membrane anchored HJV acts as a co-receptor for bone morphogenic proteins (BMPs) and activates the transcription of hepcidin, a hormone that regulates iron efflux from cells. Soluble HJV antagonizes BMP signaling and suppresses hepcidin expression. In this study we examined the trafficking and processing of HJV. Cellular HJV reached the plasma membrane without obtaining complex oligosaccharides, indicating that HJV avoided Golgi processing. Secreted HJV, in contrast, has complex oligosaccharides and can be derived from HJV with high mannose oligosaccharies at the plasma membrane. Our results support a model in which retrograde trafficking of HJV prior to cleavage is the predominant processing pathway. Release of HJV requires it to bind to the transmembrane receptor neogenin. Neogenin does not, however, play a role in HJV trafficking to the cell surface, suggesting that it could be involved either in retrograde trafficking of HJV or in cleavage leading to HJV release.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
E. B. Maryon, J. Zhang, J. W. Jellison, and J. H. Kaplan
Human Copper Transporter 1 Lacking O-Linked Glycosylation Is Proteolytically Cleaved in a Rab9-positive Endosomal Compartment
J. Biol. Chem., October 9, 2009; 284(41): 28104 - 28114.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A.-S. Zhang, F. Yang, J. Wang, H. Tsukamoto, and C. A. Enns
Hemojuvelin-Neogenin Interaction Is Required for Bone Morphogenic Protein-4-induced Hepcidin Expression
J. Biol. Chem., August 21, 2009; 284(34): 22580 - 22589.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020